BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 4118738)

  • 1. Pretibial myxedema and nonthyrotoxic thyroid disease.
    Lynch PJ; Maize JC; Sisson JC
    Arch Dermatol; 1973 Jan; 107(1):107-11. PubMed ID: 4118738
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic thrombopenic purpura. Hyperthyroidism, pretibial myxedema and L.A.T.S].
    Cattan D; Caen J; Fernandez Y; Izard J; Leclere H; Tanguy A; Lemenager J
    Presse Med (1893); 1970 Jul; 78(35):1535-40. PubMed ID: 5464336
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid responsiveness in Gravesian ophthalmopathy.
    Mendelsohn LV; Mouton DE; Goldzieher JW
    Arch Intern Med; 1972 Jul; 130(1):119-20. PubMed ID: 5067864
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myxedema tuberosum atypicum (Jadassohn-Doesserkker, 1916) in the clinical picture of the myxodermias and in the normal course of Graves-Basedow's disease].
    Rabello FE; Reis VL; Marques AS; Tendrich M; Cordeiro JG
    Med Cutan Ibero Lat Am; 1983; 11(6):399-412. PubMed ID: 6366397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
    Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
    [No Abstract]   [Full Text] [Related]  

  • 6. [Graves-Basedow type ophthalmopathy and primary hypothyroidism].
    Cathelineau G; Fribourg-Desi M
    Nouv Presse Med; 1974 Sep; 3(32):1995-8. PubMed ID: 4372586
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
    Silverstein GE; Burke G
    Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
    Tourneur R; Letonturier P; Sénécal P
    Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
    [No Abstract]   [Full Text] [Related]  

  • 9. The long-acting thyroid stimulator and thyroid disease.
    Kriss JP
    Adv Intern Med; 1970; 16():135-54. PubMed ID: 4247613
    [No Abstract]   [Full Text] [Related]  

  • 10. Dysthyroid exophthalmos.
    Fells P
    Br J Radiol; 1972 Nov; 45(539):870. PubMed ID: 4678363
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroid physiology and functional tests.
    Zellmann HE
    Major Probl Clin Surg; 1974; 15(0):55-70. PubMed ID: 4138680
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
    Wong ET; Doe RP
    Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical picture of pretibial myxedema and new aspects of diagnosis and pathogenesis].
    Kind R; Hornstein OP
    Hautarzt; 1976 Aug; 27(8):375-81. PubMed ID: 955898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid dermopathy: an underrecognized cause of leg edema.
    Kureshi F; Davis MD; Burkemper NM; Weenig RH; Pittelkow MR; Gamble GL
    Cutis; 2007 Mar; 79(3):219-24. PubMed ID: 17674588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
    Busnardo B; Accordi F; Debiasi S
    Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
    [No Abstract]   [Full Text] [Related]  

  • 16. Elephantiasic pretibial myxedema and cutis verticis gyrata caused by Graves' disease.
    Bilen H; Atasoy M; Akcay G; Akcay M; Capoglu I; Gursan N; Akbas M
    Thyroid; 2006 Aug; 16(8):815-6. PubMed ID: 16910888
    [No Abstract]   [Full Text] [Related]  

  • 17. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
    [No Abstract]   [Full Text] [Related]  

  • 18. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
    Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
    Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
    [No Abstract]   [Full Text] [Related]  

  • 19. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
    Strumia E
    Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
    [No Abstract]   [Full Text] [Related]  

  • 20. [Graves-Basedow disease, Hashimoto's disease, and myxedema from spontaneous atrophy of the thyroid. Characteristics relative to these clinical entities].
    Hennen G; Betz EH
    Acta Clin Belg; 1968; 23(1):7-22. PubMed ID: 4174753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.